StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories u.S. FDA Premarket Approvals (PMA) — Total U.S. MedTech Industry

U.S. FDA openFDA PMA Database

QuarterlyAnnualMonthly
Latest, FY2025
2,222
Period ended Dec 31, 2025
Change on a year earlier
-0.4%
2,230 in FY2024
History
12 years
Since FY2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. FDA Premarket Approvals (PMA) — Total U.S. MedTech IndustryYear on yearSource
FY2025Dec 31, 20252,222-0.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2024Dec 31, 20242,230+2.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2023Dec 31, 20232,185+4.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2022Dec 31, 20222,092-5.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2021Dec 31, 20212,204-11.9%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2020Dec 31, 20202,503-5.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2019Dec 31, 20192,638-5.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2018Dec 31, 20182,790+2.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2017Dec 31, 20172,717+6.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2016Dec 31, 20162,564+18.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2015Dec 31, 20152,169-12.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
FY2014Dec 31, 20142,485–U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗

Cite this data

StockData. (2026). Abbott Laboratories U.S. FDA Premarket Approvals (PMA) — Total U.S. MedTech Industry, annual FY2014–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-pma-ind

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.